A. Parkinson

3.3k citations
56 papers · 2.6k indexed · h-index 29

Impact in

Papers in

    • Pharmacogenetics and Drug Metabolism 39
    • Cholinesterase and Neurodegenerative Diseases 6
    • Inflammatory mediators and NSAID effects 6
    • Eicosanoids and Hypertension Pharmacology 11

A. Parkinson

55 papers receiving 2.5k citations

Peers

A. Parkinson
Comparison fields: 5 of 124
  • Pharmacology 1.2k
  • Health, Toxicology and Mutagenesis 694
  • Biochemistry 229
  • Cancer Research 435
  • Oncology 522
Replace H V Gelboin with:
H V Gelboin United States
Nobumitsu Hanioka Japan
Sang S. Park United States
Leo T. Burka United States
D W Nebert United States
Mayumi Mimura Japan
Alvito P. Alvares United States
Matti A. Lang Finland
David Kupfer United States
H. Kappus Germany
A. Parkinson relative to H V Gelboin United States H V Gelboin's profile →
Citations per field
00.5×1.5×
H V Gelboin · 1×
Citations per year

Countries citing papers authored by A. Parkinson

Since Specialization
Citations

This map shows the geographic impact of A. Parkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Parkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Parkinson more than expected).

Fields of papers citing papers by A. Parkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Parkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Parkinson. The network helps show where A. Parkinson may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Parkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Parkinson Line = papers co-authored together A. Parkinson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200548
2 2004301
3 200084
4 199926
5
Development of a non-high pressure liquid chromatography assay to determine testosterone hydroxylase (CYP3A) activity in human liver microsomes.
199833
6 19967
7 199528
8 199512
9 19959
10 1994111
11 199475
12 19939
13 199323
14 199135
15 199030
16 198859
17 198810
18 19879
19
Hexachlorobenzene and substituted pentachlorobenzenes (X-C6Cl5) as inducers of hepatic cytochrome P-450-dependent mono-oxygenases.
19864
20 198262

About A. Parkinson

A. Parkinson is a scholar working on Pharmacology, Biochemistry, Pharmaceutical Science, Pharmacology and Health, Toxicology and Mutagenesis, having authored 56 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (39 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Drug Transport and Resistance Mechanisms (10 papers), Toxic Organic Pollutants Impact (7 papers), Computational Drug Discovery Methods (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Pharmacology (1.2k citations), Health, Toxicology and Mutagenesis (694 citations), Biochemistry (229 citations), Cancer Research (435 citations) and Oncology (522 citations). A. Parkinson has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Stephen Safe, Larry W. Robertson, Thomas K. H. Chang, Wayne Levin, Bofang Yan, Ajay Madan, Dene E. Ryan, L. Safe, Linda M. Reik and S. Safe. Their work appears in journals such as Drug Metabolism and Disposition, Archives of Biochemistry and Biophysics, Chemico-Biological Interactions, Toxicology and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026